Furthermore, overexpression of EXT1 in a non-tumorigenic epithelial cell line transformed these cells to a more malignant phenotype, whereas siRNA mediated down-regulation of EXT1 in and ER-positive breast cancer cell line reduced cancer stem cell features and sensitized the cells to the chemotherapy drug, doxorubicin [24]. The gene discussed is EXT1; the disease is cancer.